Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.

Shin, Ho Cheol

Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy. [electronic resource] - The Korean journal of internal medicine Nov 2014 - 785-92 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2005-6648

10.3904/kjim.2014.29.6.785 doi


Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Biomarkers, Tumor--analysis
Chi-Square Distribution
Cyclophosphamide--administration & dosage
Disease Progression
Disease-Free Survival
Doxorubicin--administration & dosage
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse--chemistry
Male
Middle Aged
Multivariate Analysis
NF-kappa B--analysis
Neoplasm Staging
Predictive Value of Tests
Prednisone--administration & dosage
Proportional Hazards Models
Receptors, CXCR4--analysis
Retrospective Studies
Risk Factors
Rituximab
Time Factors
Treatment Outcome
Vincristine--administration & dosage
Young Adult